Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Chelation Therapy"" wg kryterium: Temat

  Lista filtrów
Wyrównaj
Wyświetlanie 1-20 z 4915

Starter badań:

Tytuł:
The impact of chelation compliance in health outcome and health related quality of life in thalassaemia patients: a systematic review.
Autorzy:
Lee WJ; Centre of Quality Management of Medicines, Faculty of Pharmacy, Universiti Kebangsaan Malaysia, Kuala Lumpur, Malaysia.
Mohd Tahir NA; Centre of Quality Management of Medicines, Faculty of Pharmacy, Universiti Kebangsaan Malaysia, Kuala Lumpur, Malaysia. .
Chun GY; Centre of Quality Management of Medicines, Faculty of Pharmacy, Universiti Kebangsaan Malaysia, Kuala Lumpur, Malaysia.
Li SC; School of Biomedical Sciences and Pharmacy, College of Health, Medicine and Wellbeing, University of Newcastle, New South Wales, Australia.
Pokaż więcej
Źródło:
Health and quality of life outcomes [Health Qual Life Outcomes] 2024 Feb 02; Vol. 22 (1), pp. 14. Date of Electronic Publication: 2024 Feb 02.
Typ publikacji:
Systematic Review; Journal Article; Review
MeSH Terms:
Iron Chelating Agents*/therapeutic use
Thalassemia*/drug therapy
Humans ; Deferasirox ; Deferiprone ; Deferoxamine/therapeutic use ; Quality of Life ; Pyridones/adverse effects ; Benzoates/adverse effects ; Triazoles/adverse effects ; Chelation Therapy ; Ferritins ; Outcome Assessment, Health Care
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Drug Selection and Posology, Optimal Therapies and Risk/Benefit Assessment in Medicine: The Paradigm of Iron-Chelating Drugs.
Autorzy:
Kontoghiorghes GJ; Postgraduate Research Institute of Science, Technology, Environment and Medicine, Limassol 3021, Cyprus.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2023 Nov 25; Vol. 24 (23). Date of Electronic Publication: 2023 Nov 25.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Iron Overload*/etiology
Iron Overload*/chemically induced
beta-Thalassemia*/drug therapy
beta-Thalassemia*/complications
Humans ; Deferiprone/therapeutic use ; Deferoxamine/therapeutic use ; Pyridones/adverse effects ; Iron Chelating Agents/adverse effects ; Chelation Therapy/methods ; Iron/metabolism ; Drug Therapy, Combination
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Multipurpose Iron-Chelating Ligands Inspired by Bioavailable Molecules.
Autorzy:
Cini E; Department of Biotechnology, Chemistry and Pharmacy, University of Siena, Via Aldo Moro 2, 53100 Siena, Italy.
Crisponi G; Dipartimento di Scienze della Vita e dell'Ambiente, Cittadella Universitaria, 09042 Monserrato-Cagliari, Italy.
Fantasia A; Dipartimento di Scienze della Vita e dell'Ambiente, Cittadella Universitaria, 09042 Monserrato-Cagliari, Italy.
Cappai R; Dipartimento di Scienze Chimiche, Fisiche, Matematiche e Naturali, University of Sassari, Via Vienna 2, 07100 Sassari, Italy.
Siciliano S; Department of Biotechnology, Chemistry and Pharmacy, University of Siena, Via Aldo Moro 2, 53100 Siena, Italy.
Florio GD; Department of Biotechnology, Chemistry and Pharmacy, University of Siena, Via Aldo Moro 2, 53100 Siena, Italy.
Nurchi VM; Dipartimento di Scienze della Vita e dell'Ambiente, Cittadella Universitaria, 09042 Monserrato-Cagliari, Italy.
Corsini M; Department of Biotechnology, Chemistry and Pharmacy, University of Siena, Via Aldo Moro 2, 53100 Siena, Italy.
Pokaż więcej
Źródło:
Biomolecules [Biomolecules] 2024 Jan 11; Vol. 14 (1). Date of Electronic Publication: 2024 Jan 11.
Typ publikacji:
Journal Article
MeSH Terms:
Iron Chelating Agents*
Biological Products*
Iron ; Chelation Therapy ; Colorimetry ; Ligands
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Erythrocytapheresis in Children and Young Adults with Hemoglobinopathies and Iron Overload in Need of Iron Chelation Therapy.
Autorzy:
van Hattem, Jessica (AUTHOR)
Maes, Philip (AUTHOR)
Esterhuizen, Tonya Marianne (AUTHOR)
Devos, Ann (AUTHOR)
Ruppert, Martin (AUTHOR)
van Heerden, Jaques (AUTHOR)
Pokaż więcej
Źródło:
Journal of Clinical Medicine. Oct2023, Vol. 12 Issue 19, p6287. 12p.
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
造血細胞移植後の肝障害の鑑別に MRI が有用であった輸血後鉄過剰症の 2 小児例
Autorzy:
鷲尾佳奈
塩飽孝宏
為房宏輔
越智元春
石田悠志
金光喜一郎
藤原かおり
塚原宏
Pokaż więcej
Alternatywny tytuł:
TWO PEDIATRIC CASES OF POST-TRANSFUSION IRON OVERLOAD IN WHICH MRI WAS USEFUL FOR DIFFERENTIATING LIVER INJURY AFTER HEMATOPOIETIC CELL TRANSPLANTATION.
Źródło:
Japanese Journal of Transfusion & Cell Therapy / Nihon Yuketsu Saibo Chiryo Gakkaishi. 2023, Vol. 69 Issue 5, p605-609. 5p.
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Economic burden of adult patients with β-thalassaemia major in mainland China.
Autorzy:
Zhen, Xuemei (AUTHOR)
Ming, Jing (AUTHOR)
Zhang, Runqi (AUTHOR)
Zhang, Shuo (AUTHOR)
Xie, Jing (AUTHOR)
Liu, Baoguo (AUTHOR)
Wang, Zijing (AUTHOR)
Sun, Xiaojie (AUTHOR)
Shi, Lizheng (AUTHOR)
Pokaż więcej
Źródło:
Orphanet Journal of Rare Diseases. 8/29/2023, Vol. 18 Issue 1, p1-8. 8p.
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Effect of chelation therapy on arrhythmogenic and basal ECG parameters of lead exposed workers.
Autorzy:
Karanfil M; Department of Cardiology, Ankara City Hospital, Ankara, Turkey.
Gündüzöz M; Ankara Occupational and Environmental Diseases Hospital, Ankara, Turkey.
Karakurt M; Ankara Occupational and Environmental Diseases Hospital, Ankara, Turkey.
Aruğaslan E; Department of Cardiology, Ankara City Hospital, Ankara, Turkey.
Özbay MB; Department of Cardiology, Ankara City Hospital, Ankara, Turkey.
Ünal S; Department of Cardiology, Ankara City Hospital, Ankara, Turkey.
Akbuğa K; Rıdvan Ege Medical Faculty, Department of Cardiology, Ufuk University, Ankara, Turkey.
Akdi A; Department of Cardiology, Ankara City Hospital, Ankara, Turkey.
Erdöl MA; Department of Cardiology, Ankara City Hospital, Ankara, Turkey.
Ertem AG; Department of Cardiology, Ankara City Hospital, Ankara, Turkey.
Yayla Ç; Department of Cardiology, Ankara City Hospital, Ankara, Turkey.
Özeke Ö; Department of Cardiology, Ankara City Hospital, Ankara, Turkey.
Pokaż więcej
Źródło:
Archives of environmental & occupational health [Arch Environ Occup Health] 2022; Vol. 77 (5), pp. 382-388. Date of Electronic Publication: 2021 Apr 10.
Typ publikacji:
Journal Article
MeSH Terms:
Chelation Therapy*
Lead*
Arrhythmias, Cardiac/chemically induced ; Electrocardiography ; Humans
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
A Study to Assess and Improve Adherence to Iron Chelation Therapy in Transfusion-Dependent Thalassemia Patients.
Autorzy:
Theppornpitak K; Department of Pediatrics, Faculty of Medicine, King Chulalongkorn Memorial Hospital, Chulalongkorn University, Bangkok, Thailand.
Trakarnsanga B; Pharmacy Department, King Chulalongkorn Memorial Hospital University, Bangkok, Thailand.
Lauhasurayotin S; Department of Pediatrics, Faculty of Medicine, Clinical Research for Holistic Management in Pediatric Hematology and Oncology, Chulalongkorn University, Bangkok, Thailand.
Poparn H; Department of Pediatrics, Faculty of Medicine, Clinical Research for Holistic Management in Pediatric Hematology and Oncology, Chulalongkorn University, Bangkok, Thailand.
Chiengthong K; Department of Pediatrics, Faculty of Medicine, Clinical Research for Holistic Management in Pediatric Hematology and Oncology, Chulalongkorn University, Bangkok, Thailand.
Sosothikul D; Department of Pediatrics, Faculty of Medicine, Clinical Research for Holistic Management in Pediatric Hematology and Oncology, Chulalongkorn University, Bangkok, Thailand.
Techavichit P; Department of Pediatrics, Faculty of Medicine, Clinical Research for Holistic Management in Pediatric Hematology and Oncology, Chulalongkorn University, Bangkok, Thailand.
Pokaż więcej
Źródło:
Hemoglobin [Hemoglobin] 2021 May; Vol. 45 (3), pp. 171-174. Date of Electronic Publication: 2021 Jun 08.
Typ publikacji:
Journal Article
MeSH Terms:
Chelation Therapy*
Iron Chelating Agents*/therapeutic use
Iron Overload*/drug therapy
Iron Overload*/etiology
Thalassemia*/drug therapy
Benzoates/therapeutic use ; Child ; Cross-Sectional Studies ; Deferasirox/therapeutic use ; Female ; Humans ; Iron ; Male
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
A Multicenter ICET-A Study on Age at Menarche and Menstrual Cycles in Patients with Transfusion-Dependent Thalassemia (TDT) who Started Early Chelation Therapy with Different Chelating Agents.
Autorzy:
Di Maio, Salvatore
Marzuillo, Pierluigi
Daar, Shahina
Kattamis, Christos
Karimi, Mehran
Forough, Saki
Banchev, Atanas
Kaleva, Valeria
Christou, Soteroula
Fortugno, Carmelo
Delaporta, Polyxeni
Soliman, Ashraf T.
Tzoulis, Ploutarchos
de Sanctis, Vincenzo
Pokaż więcej
Źródło:
Mediterranean Journal of Hematology & Infectious Diseases. 2023, Vol. 15 Issue 1, p1-8. 8p.
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Endocrine Complications and the Effect of Compliance with Chelation Therapy in Patients with Beta Thalassemia Major in Eastern Province of Saudi Arabia.
Autorzy:
Habbash, Fatema (AUTHOR)
Al-Bati, Wegdan (AUTHOR)
Al-Hashim, Howra (AUTHOR)
Aldossari, Maryam (AUTHOR)
Alali, Ahmed (AUTHOR)
Alalyani, Khalid (AUTHOR)
Al-Ebrahim, Zainab (AUTHOR)
Hamed, Nouf (AUTHOR)
Eraqe, Samma (AUTHOR)
Binayfan, Ziyad (AUTHOR)
Marri, Azzam Al (AUTHOR)
Aljaber, Thamer (AUTHOR)
Pokaż więcej
Źródło:
Journal of Blood Medicine. Dec2022, Vol. 13, p763-774. 12p.
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Clinical view versus guideline adherence in ferritin monitoring and initiating iron chelation therapy in patients with myelodysplastic syndromes.
Autorzy:
Rozema, Johanne (AUTHOR)
van Asten, Ivar (AUTHOR)
Kwant, Beau (AUTHOR)
Kibbelaar, Robby E. (AUTHOR)
Veeger, Nic J. G. M. (AUTHOR)
de Wit, Harry (AUTHOR)
van Roon, Eric N. (AUTHOR)
Hoogendoorn, Mels (AUTHOR)
Pokaż więcej
Źródło:
European Journal of Haematology. Dec2022, Vol. 109 Issue 6, p772-778. 7p.
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Effects of iron chelation therapy on the clinical course of aceruloplasminemia: an analysis of aggregated case reports.
Autorzy:
Vroegindeweij LHP; Department of Internal Medicine, Center for Lysosomal and Metabolic Diseases, Porphyria Center Rotterdam, Erasmus MC University Medical Center Rotterdam, Rotterdam, The Netherlands.
Boon AJW; Department of Neurology, Erasmus MC University Medical Center, Rotterdam, The Netherlands.
Wilson JHP; Department of Internal Medicine, Center for Lysosomal and Metabolic Diseases, Porphyria Center Rotterdam, Erasmus MC University Medical Center Rotterdam, Rotterdam, The Netherlands.
Langendonk JG; Department of Internal Medicine, Center for Lysosomal and Metabolic Diseases, Porphyria Center Rotterdam, Erasmus MC University Medical Center Rotterdam, Rotterdam, The Netherlands. .
Pokaż więcej
Źródło:
Orphanet journal of rare diseases [Orphanet J Rare Dis] 2020 Apr 25; Vol. 15 (1), pp. 105. Date of Electronic Publication: 2020 Apr 25.
Typ publikacji:
Case Reports; Journal Article
MeSH Terms:
Chelation Therapy*
Iron Metabolism Disorders*/drug therapy
Ceruloplasmin/deficiency ; Humans ; Iron ; Middle Aged ; Neurodegenerative Diseases
SCR Disease Name:
Familial apoceruloplasmin deficiency
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Metal Chelation Therapy and Parkinson's Disease: A Critical Review on the Thermodynamics of Complex Formation between Relevant Metal Ions and Promising or Established Drugs.
Autorzy:
Tosato M; Analytical Chemistry Research Group, Department of Chemical Sciences, University of Padova, via Marzolo 1, 35131 Padova, Italy.
Di Marco V; Analytical Chemistry Research Group, Department of Chemical Sciences, University of Padova, via Marzolo 1, 35131 Padova, Italy. .
Pokaż więcej
Źródło:
Biomolecules [Biomolecules] 2019 Jul 09; Vol. 9 (7). Date of Electronic Publication: 2019 Jul 09.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Chelation Therapy*
Chelating Agents/*therapeutic use
Coordination Complexes/*therapeutic use
Metals, Heavy/*therapeutic use
Neuroprotective Agents/*therapeutic use
Parkinson Disease/*drug therapy
Chelating Agents/chemical synthesis ; Chelating Agents/chemistry ; Coordination Complexes/chemical synthesis ; Coordination Complexes/chemistry ; Humans ; Ligands ; Metals, Heavy/chemical synthesis ; Metals, Heavy/chemistry ; Neuroprotective Agents/chemical synthesis ; Neuroprotective Agents/chemistry ; Thermodynamics
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
A natural history of lower-risk myelodysplastic syndromes with ring sideroblasts: an analysis of the MDS-CAN registry.
Autorzy:
Buckstein R; Division of Medical Oncology & Hematology, Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto, ON, Canada.; Department of Medicine, University of Toronto, Toronto, ON, Canada.
Chodirker L; Division of Medical Oncology & Hematology, Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto, ON, Canada.; Department of Medicine, University of Toronto, Toronto, ON, Canada.
Mozessohn L; Division of Medical Oncology & Hematology, Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto, ON, Canada.; Department of Medicine, University of Toronto, Toronto, ON, Canada.
Yee KWL; Department of Medicine, University of Toronto, Toronto, ON, Canada.; Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.
Geddes M; Tom Baker Cancer Centre, Calgary, AB, Canada.
Zhu N; Division of Hematology, University of Alberta, Edmonton, AB, Canada.
Shamy A; Jewish General Hospital, Montréal, QC, Canada.
Leitch HA; St. Paul's Hospital, University of British Columbia, Vancouver, BC, Canada.
Christou G; Ottawa Hospital Research Institute, University of Ottawa, Ottawa, ON, Canada.
Banerji V; CancerCare Manitoba, Winnipeg, MB, Canada.
Brian L; Juravinski Cancer Centre, Hamilton Health Sciences, Hamilton, ON, Canada.
Khalaf D; Juravinski Cancer Centre, Hamilton Health Sciences, Hamilton, ON, Canada.
St-Hilaire E; Centre Hospitalier Universitaire Dr. Georges-L.-Dumont, Moncton, NB, Canada.
Finn N; Centre Hospitalier Universitaire Dr. Georges-L.-Dumont, Moncton, NB, Canada.
Nevill T; Division of Hematology, Leukemia/Bone Marrow Transplant Program of BC, BC Cancer, University of British Columbia, Vancouver, BC, Canada.
Keating MM; Division of Hematology, Dalhousie University, Halifax, NS, Canada.
Storring J; McGill University Health Centre, Montréal, QC, Canada.
Delage R; CHU de Québec, Hôpital de l'Enfant-Jésus, Centre Universitaire d'Hématologie et d'Oncologie de Québec, Québec, QC, Canada.
Parmentier A; Division of Medical Oncology & Hematology, Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto, ON, Canada.
Thambipillai A; Division of Medical Oncology & Hematology, Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto, ON, Canada.
Siddiqui M; Division of Medical Oncology & Hematology, Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto, ON, Canada.
Westcott C; Celgene Inc., a Bristol-Myers Squibb Company, Mississauga, ON, Canada.
Cameron C; Value and Evidence Division, Marketing & Market Access, EVERSANA™, Sydney, NS, Canada.
Mamedov A; Division of Medical Oncology & Hematology, Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto, ON, Canada.
Spin P; Value and Evidence Division, Marketing & Market Access, EVERSANA™, Sydney, NS, Canada.
Tang D; Bristol Myers Squibb, Princeton, NJ, USA.
Pokaż więcej
Źródło:
Leukemia & lymphoma [Leuk Lymphoma] 2022 Dec; Vol. 63 (13), pp. 3165-3174. Date of Electronic Publication: 2022 Sep 12.
Typ publikacji:
Clinical Study; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Myelodysplastic Syndromes*/diagnosis
Myelodysplastic Syndromes*/epidemiology
Myelodysplastic Syndromes*/therapy
Humans ; Chelation Therapy ; Prognosis ; Quality of Life ; Registries
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Wyświetlanie 1-20 z 4915

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies